<unk> , sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. It blocks thymic stromal lymphopoietin (TSLP), an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation. It was approved for medical use in the United States in December 2021.
Tezepelumab
Olaratumab
Ustekinumab
Emapalumab
Evolocumab
Lanadelumab
Tralokinumab
Evinacumab